RNF43 is frequently mutated in colorectal and endometrial cancers
Author(s)
Giannakis, Marios; Hodis, Eran; Jasmine Mu, Xinmeng; Yamauchi, Mai; Rosenbluh, Joseph; Cibulskis, Kristian; Saksena, Gordon; Lawrence, Michael S; Qian, Zhi Rong; Nishihara, Reiko; Van Allen, Eliezer M; Hahn, William C; Gabriel, Stacey B; Getz, Gad; Ogino, Shuji; Fuchs, Charles S; Garraway, Levi A; Lander, Eric Steven; ... Show more Show less
Downloadnihms648689.pdf (595.0Kb)
PUBLISHER_POLICY
Publisher Policy
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Terms of use
Metadata
Show full item recordAbstract
We report somatic mutations of RNF43 in over 18% of colorectal adenocarcinomas and endometrial carcinomas. RNF43 encodes an E3 ubiquitin ligase that negatively regulates Wnt signaling. Truncating mutations of RNF43 are more prevalent in microsatellite-unstable tumors and show mutual exclusivity with inactivating APC mutations in colorectal adenocarcinomas. These results indicate that RNF43 is one of the most commonly mutated genes in colorectal and endometrial cancers.
Date issued
2014-10Department
Massachusetts Institute of Technology. Department of BiologyJournal
Nature Genetics
Publisher
Nature Publishing Group
Citation
Giannakis, Marios et al. “RNF43 Is Frequently Mutated in Colorectal and Endometrial Cancers.” Nature Genetics 46, 12 (October 2014): 1264–1266 © 2014 Nature America, Inc
Version: Author's final manuscript
ISSN
1061-4036
1546-1718